These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7636861)

  • 21. (+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties.
    Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Pittalà V; Pappalardo MS; Cacciaguerra S; Spampinato S
    J Med Chem; 1998 May; 41(10):1574-80. PubMed ID: 9572883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
    He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
    J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-(3-Fluoropropyl)-N-normetazocine, a potentially useful opiate antagonist for opiate receptor studies with positron emission tomography (PET).
    Feliu AL; Holland MJ; Carr KD; Fowler JS; Simon EJ
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):323-36. PubMed ID: 2997887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 1,5-benzodiazepines as CCK-B ligands. Effect of aryl-carbamic substituents at the C-3 position together with halogen substitution on the benzo-fused ring.
    Tranquillini ME; Cassarà PG; Corsi M; Curotto G; Donati D; Finizia G; Pentassuglia G; Polinelli S; Tarzia G; Ursini A; van Amsterdam FT
    Arch Pharm (Weinheim); 1997 Nov; 330(11):353-7. PubMed ID: 9431027
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of trishomocubanes on sigma receptor binding of N-(1-benzyl-piperidin-4-yl)-4-[123I]iodobenzamide in vivo in the rat brain.
    Liu X; Mattner F; Katsifis A; Christie M; Kassiou M
    Med Chem; 2005 Jan; 1(1):31-8. PubMed ID: 16789883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical effects of N-cyanoalkyl substituents upon the activities of several classes of opioids.
    Jacobson AE; Rice KC; Reden J; Lupinacci L; Brossi A; Streaty RA; Klee WA
    J Med Chem; 1979 Mar; 22(3):328-31. PubMed ID: 218015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.
    Wentland MP; VanAlstine M; Kucejko R; Lou R; Cohen DJ; Parkhill AL; Bidlack JM
    J Med Chem; 2006 Sep; 49(18):5635-9. PubMed ID: 16942039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
    John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
    J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY
    Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiophene bioisosteres of spirocyclic σ receptor ligands: relationships between substitution pattern and σ receptor affinity.
    Oberdorf C; Schepmann D; Vela JM; Buschmann H; Holenz J; Wünsch B
    J Med Chem; 2012 Jun; 55(11):5350-60. PubMed ID: 22515405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sigma receptor activation does not mediate fentanyl-induced attenuation of muscarinic coronary contraction.
    Tsuchida H; Schubert A; Estafanous FG; Brum JM; Murray PA
    Anesth Analg; 1996 May; 82(5):982-7. PubMed ID: 8610910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Para-substituted Phe3 deltorphin analogues: enhanced selectivity of halogenated derivatives for delta opioid receptor sites.
    Salvadori S; Bianchi C; Lazarus LH; Scaranari V; Attila M; Tomatis R
    J Med Chem; 1992 Dec; 35(25):4651-7. PubMed ID: 1335080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between the structure of 6-substituted 6,8-diazabicyclo[3.2.2]nonan-2-ones and their sigma receptor affinity and cytotoxic activity.
    Holl R; Schepmann D; Bednarski PJ; Grünert R; Wünsch B
    Bioorg Med Chem; 2009 Feb; 17(4):1445-55. PubMed ID: 19196515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro evaluation of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: high-affinity ligands for the N,N'-di-o-tolylguanidine-labeled sigma binding site.
    Mewshaw RE; Sherrill RG; Mathew RM; Kaiser C; Bailey MA; Karbon EW
    J Med Chem; 1993 Feb; 36(3):343-52. PubMed ID: 8426363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepancies in characterization of sigma sites in the mouse central nervous system.
    Kovács KJ; Larson AA
    Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes.
    de Costa BR; Dominguez C; He XS; Williams W; Radesca L; Bowen W
    J Med Chem; 1992 Nov; 35(23):4334-43. PubMed ID: 1447735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.